-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Suspends Overweight Rating on Akero Therapeutics

Benzinga·12/10/2025 13:56:24
Listen to the news
Cantor Fitzgerald suspends Overweight rating on Akero Therapeutics (NASDAQ:AKRO).